Of course I would dump them if any anns would suggests it is all over with no chance of survival. But as long as Hopper holds his up to19.99% direct interest this company will survive. When in Rome do as the Romans do, when holding Hopper companies do as Hopper does.
I had worried about any new CEO, but RM looks to be a great replacement. Hopper got a list of comps that recently raised capital from me to ring them to get a much better CR done as the last ones as those supported comps with much higher MCs and definitely less asset values. That way, no excuse to blame the market. Even Bell Potter supported one very well " behaved ".
Between the lines RM must have been pleased with the 3 dosed AML patients and the dose escalation so far and her comments on CDH17 having already FDA support for a PH2, safety permitting, was new to me and sounds great. Imagine what the licence alone would get sold for if Hopper puts it up for sale. Definitely more than the current EV.
GLTA
CHM Price at posting:
1.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)